FOXM1 expression is significantly associated with chemotherapy resistance and adverse prognosis in non-serous epithelial ovarian cancer patients.

Tassi RA, Todeschini P, Siegel ER, Calza S, Cappella P, Ardighieri L, Cadei M, Bugatti M, Romani C, Bandiera E, Zanotti L, Tassone L, Guarino D, Santonocito C, Capoluongo ED, Beltrame L, Erba E, Marchini S, D'Incalci M, Donzelli C, Santin AD, Pecorelli S, Sartori E, Bignotti E, Odicino F, Ravaggi A

Open source

DOI: 10.1186/s13046-017-0536-y
Published: 2017 May 8
Container: Journal of experimental & clinical cancer research : CR
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1186/s13046-017-0536-y,
  title = {FOXM1 expression is significantly associated with chemotherapy resistance and adverse prognosis in non-serous epithelial ovarian cancer patients.},
  author = {Tassi RA and Todeschini P and Siegel ER and Calza S and Cappella P and Ardighieri L and Cadei M and Bugatti M and Romani C and Bandiera E and Zanotti L and Tassone L and Guarino D and Santonocito C and Capoluongo ED and Beltrame L and Erba E and Marchini S and D'Incalci M and Donzelli C and Santin AD and Pecorelli S and Sartori E and Bignotti E and Odicino F and Ravaggi A},
  year = {2017},
  journal = {Journal of experimental \& clinical cancer research : CR},
  doi = {10.1186/s13046-017-0536-y},
  url = {https://doi.org/10.1186/s13046-017-0536-y}
}

RIS

TY  - JOUR
TI  - FOXM1 expression is significantly associated with chemotherapy resistance and adverse prognosis in non-serous epithelial ovarian cancer patients.
AU  - Tassi RA
AU  - Todeschini P
AU  - Siegel ER
AU  - Calza S
AU  - Cappella P
AU  - Ardighieri L
AU  - Cadei M
AU  - Bugatti M
AU  - Romani C
AU  - Bandiera E
AU  - Zanotti L
AU  - Tassone L
AU  - Guarino D
AU  - Santonocito C
AU  - Capoluongo ED
AU  - Beltrame L
AU  - Erba E
AU  - Marchini S
AU  - D'Incalci M
AU  - Donzelli C
AU  - Santin AD
AU  - Pecorelli S
AU  - Sartori E
AU  - Bignotti E
AU  - Odicino F
AU  - Ravaggi A
PY  - 2017
JO  - Journal of experimental & clinical cancer research : CR
DO  - 10.1186/s13046-017-0536-y
UR  - https://doi.org/10.1186/s13046-017-0536-y
ER  -

APA

RA, T., P, T., ER, S., S, C., P, C., L, A., M, C., M, B., C, R., E, B., L, Z., L, T., D, G., C, S., ED, C., L, B., E, E., S, M., M, D., C, D., AD, S., S, P., E, S., E, B., F, O., & A, R. (2017). FOXM1 expression is significantly associated with chemotherapy resistance and adverse prognosis in non-serous epithelial ovarian cancer patients.. Journal of experimental & clinical cancer research : CR. https://doi.org/10.1186/s13046-017-0536-y

Source records

pubmed · retrieved 2026-09-27T13:11:38.575Z